Regulation of 11β‐hydroxysteroid dehydrogenase type 1 and glucose‐stimulated insulin secretion in pancreatic islets of Langerhans
Henrik Ortsäter(Uppsala University), Peter Bergsten(Uppsala University), Lars Abrahmsén(Swedish Orphan Biovitrum (Sweden)), Pēteris Alberts(Maxygen (United States)), Ulrika Warpman Berglund(Orexo (Sweden)), Lars O. M. Engblom(Swedish Orphan Biovitrum (Sweden))
Cited by 30
Related Papers
Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Improves Hepatic Insulin Sensitivity in Hyperglycemic Mice Strains
|Endocrinology|2003|263
Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice
|Diabetologia|2002|259
Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes
|Journal of Endocrinology|2014|214
Arylsulfonamidothiazoles as a New Class of Potential Antidiabetic Drugs. Discovery of Potent and Selective Inhibitors of the 11β-Hydroxysteroid Dehydrogenase Type 1
|Journal of Medicinal Chemistry|2002|211
The advent of oncolytic virotherapy in oncology: The Rigvir® story
|European Journal of Pharmacology|2018|179